对肝脏脑病的诊断和治疗的实用方法
Nancy Reau1, David Bernstein2, Paul Kwo3
1Rush University Medical Center, Chicago, IL.
The American journal of medicine
|September 3, 2025
概括
肝脏脑病的治疗需要更好地遵守指南. 本实用指南简化了患者,护理人员和医疗专业人员的诊断和治疗途径,以改善结果.
科学领域:
- 肝病学
- 胃肠病学
- 临床医学
背景情况:
- 肝脏脑病 (HE) 是不补偿性肝硬化的一个常见的可逆并发症.
- 反复出现的HE病例显著增加了发病率,死亡率和医疗费用.
- 目前的采用和遵守已建立的高等教育管理准则是不理想的.
研究的目的:
- 倡导现有的高等教育诊断和管理建议更加务实地应用.
- 提供对HE查,诊断和管理的结构化临床护理途径.
- 提供适合患者,护理人员和卫生保健专业人员的实用资源.
主要方法:
- 这是一个多学科的圆桌讨论,
- 审查当前的高等教育指导方针和相关的同行评审文献.
- 专注于实用的高等教育管理策略的临床护理出版物的开发.
主要成果:
- 这是一本全面的出版物,提供了对高等教育诊断和管理的实用方法.
- 一个明确的初始管理,长期维护和预防HE的途径.
- 为患者,护理人员和医疗保健提供者提供有针对性的资源.
结论:
- 更好地遵守实际的高等教育指导方针可以提高临床识别和诊断.
- 结构化的护理途径有助于有效的初始管理,维护和预防策略.
- 能够获得的资源对于支持所有利益相关者管理肝脏脑病至关重要.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
135
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
135
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Acute Pancreatitis II: Clinical Manifestations and Management
175
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
175
Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666


